Safety and tolerability of a combined oral contraceptive containing estetrol/drospirenone in real-life clinical practice: An open-label, prospective, multicenter, epidemiological, observational program "Estetiko"

Aim. To evaluate the safety and acceptability of a combined oral contraceptive (COC) containing estetrol 15 mg and drospirenone 3 mg when taken for 6 cycles in real clinical practice. Materials and methods. An open-label prospective multicenter (in 20 cities of the Russian Federation) epidemiolog...

Full description

Saved in:
Bibliographic Details
Main Authors: Natalia V. Aganezova, Rushania I. Gabidullina
Format: Article
Language:Russian
Published: IP Berlin A.V. 2025-01-01
Series:Гинекология
Subjects:
Online Access:https://gynecology.orscience.ru/2079-5831/article/viewFile/684721/199569
Tags: Add Tag
No Tags, Be the first to tag this record!